Full Year 2024 Net Loss of $48.8 Million Compared to Net Loss of $65.1 Million in 2023 Full Year 2024 Adjusted EBITDA of $46.2 Million Compared to $40.8 Million in 2023 Increased Quarterly and Annual Operational Cash Flow Compared to Prior Periods to $7.2 Million and $21.6 Million, Respectively Five New Dispensaries Open Since the End of Q3 2024 and Three More Planned by Summer 2025 BOCA RATON, Fla., March 06, 2025 (GLOBE... Read More